Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You’ll have to do your own DD I can’t do it for you
Dilution is common with companies. It isn't fraud or corruption.
It’s very clear at this point they are diluting millions of shares. Just recently they increased the authorized shares only to be able to dilute to stay in business
IMO
That's a little extreme. Are you saying the numbers they are reporting are fraudulent?
Cannabis creates mass eaters, not mass shooters.
*****I care period , 18 million per year guaranteed
Yehaaa
ENOUGH SAID ? NA !
Who cares lol all that is old news tilray is loosing money not making it.
*****LOL !!! Pot producer Tilray to buy rival Hexo's remaining debt of $193 mln
Quote:
Hexo will pay Tilray an annual fee of $18 million for advisory services related to cultivation, operations, and production, the company said on Tuesday.
Quote:
Once Tilray takes over the debt, Hexo will pay Tilray 5% annual interest on said debt (so about $9.6 million), and also pay Tilray $18 million annually for "advisory services" (so about $27.6 million annually in total). Tilray notes that this makes the deal "immediately accretive" to Tilray's profits.
HEXO Enters Into Definitive Agreement With Tilray Brands to Create a Strategic Alliance Between Two Canadian Cannabis Leaders
Quote:
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 11, 2021 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021.
New debt financing arrangement will accelerate HEXO’s transformation into a cash flow positive business within the next four quarters
HEXO and Tilray Brands to target combined cost-savings of up to U.S.$80M within 24 months to be realized from shared support services, commercial alliances and production efficiencies
ANYTHING IN THE MID 2 DOLLAR RANGE I WILL LOAD UP HUGE PERIOD
ENOUGH SAID
The link between pot and mass shootings may be closer than we think
https://nypost.com/2019/08/07/the-link-between-pot-and-mass-shootings-may-be-closer-than-we-think/
*****Hmmm thought TLRY was going under 2 bucks ?
ENOUGH SAID !
This company is straight up garbage imo can’t believe it’s still trading… should have been closed down a long time ago. Long history or fraud and corruption in management team. IMO
Struggles to hold the $4’s, not a good sign.
No one ordering products this will go to zero within a month
OCS having issues with ordering from LP’s their stores are drying up and they are letting employees go.
OCS was hit with spam bots two weeks ago causing their servers to go down.
This issue has not been fixed nor will it be fixed in the near future.
All LP’s cannot ship to OCS due to this issue. Looks like more companies will go bankrupt due to not being able to ship and get paid for their products for months down the road
Imo
$50's are coming with legalization. Not before that.
$5 and $5.85 (200 day MA) would be next ceilings of resistance
we will see next week how pps holds up.
$5's coming
TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support patients through their medical cannabis journey.
Blair MacNeil, President, Tilray Canada, said, "We're proud to expand our medical cannabis portfolio in Canada and broaden our offerings for our growing patient community. Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed."
In Canada, Tilray Medical offers a broad portfolio of medical cannabis brands including Tilray, Aphria, Broken Coast, and Symbios. Understanding that patient needs are unique, Tilray Medical's latest release of high-quality medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products:
SYDNEY, Australia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has received approval and verification from The Natural Health Science Foundation ("NHSF") of its flagship product, Tilray Purified Oral Solution ("OS") CBD100, to be used in clinical trials in Australia and New Zealand.
Tilray Medical Launches New Products and ‘CannaPoints’ Program to Support Patients Across Canada
August 25, 2022 at 7:00 AM EDT
TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support patients through their medical cannabis journey.
Blair MacNeil, President, Tilray Canada, said, "We’re proud to expand our medical cannabis portfolio in Canada and broaden our offerings for our growing patient community. Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed."
In Canada, Tilray Medical offers a broad portfolio of medical cannabis brands including Tilray, Aphria, Broken Coast, and Symbios. Understanding that patient needs are unique, Tilray Medical’s latest release of high-quality medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products:
Tilray:
Tilray Sinaloa Gold: A high THC sativa strain. Terpenes include d-Limonene, beta-Myrcene, and beta-Caryophyllene.
Tilray Sapphire Scout: A genetic blend of Girl Scout Cookies crossed with True OG. Terpenes include Limonene, Linalool, and Trans-Caryophyllene.
Tilray Chem Cookies: Chem Cookies is a result of two cannabis strains: Chemdawg #4 and Girl Scout Cookies (a.k.a. GSC). Terpenes include d-Limonene, beta-Myrcene, and beta-Caryophyllene.
Tilray Powdered Donuts #8: Powdered Donuts #8 is a high-THC strain. Terpenes include d-Limonene, beta-Myrcene, and beta-Caryophyllene.
Aphria:
Aphria Sherbet Cookies: Sherbet Cookies is a high THC hybrid strain. Terpenes include Humulene, Nerolidol and beta-Caryophyllene.
Aphria Banana Punch: Banana Punch is a high THC hybrid strain made from Banana OG and Purple Punch. Terpenes include limonene, pinene and beta-Caryophyllene.
Aphria Monkey Butter: Monkey Butter is another high THC hybrid strain made from the combination of Gorilla Glue #4 x Peanut Butter Breath. Terpenes also include: Humulene, Cedrene, and beta-Caryophyllene.
To further support the medical cannabis journey for patients, Tilray Medical partnered with Strainprint, a mobile app focused on medical cannabis tracking, to develop the CannaPoints program. Alongside advice from a physician, Tilray Medical patients can use the CannaPoints program to explore new offerings, learn more about strain details, and record the effects, making it easier for them to curate optimal personal consumption schedules, empowering them to tailor their own experiences and earn rewards through the app in the process. Patients can download the app for FREE, and kickstart their journey on the App Store, or Google Play for Apple and Android devices.
About Tilray Medical
Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, and Symbios. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in 20 countries and across five continents.
For more information on Tilray Medical, visit Tilray Medical Canada and follow @TilrayMedical on Instagram.
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience of health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.
For more information on how we open a world of wellbeing, visit www.Tilray.com and follow @Tilray on all social platforms.
Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.
Contacts:
Tilray Global:
Kaitlin Macapagal
news@tilray.com
Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com
Wait, I thought the moon launch was Monday.
Seeing Higher highs and higher lows?
Since end of June. We'll see soon enough....but support occurred around $3.50ish...
*****Hmmm thought TLRY was going under 2 bucks ?
ENOUGH SAID !
TLTY appears to struggle holding the 4’s.
Good luck .......
More good news: Tilray Medical has received approval and verification from The Natural Health Science Foundation of its flagship product, Tilray Purified Oral Solution CBD100, to be used in clinical trials in Australia and New Zealand.
Details bit.ly/3T94yUq $TLRY
I Picked Up a Few At $3.51
And it looks like more may become available between $3-$3.51 ish in coming weeks.
Will see if support stays above $3.50ish...and breaks below. After hours suggest good support at $3.51....but that's for today....lol
I don't think this will see 2's.....but, again...never say never. Technically, odds are against....unless there is bad news about US mj legislation.
Wow, major downturn! I'm glad I stayed patient and didn't buy in the 4s. It looks like a down week for the markets in anticipation of Fed statements at Jackson Hole. I might buy in at low 3s.
Ok I problaby will see some 2s sooner or later.
Wow, major downturn! I'm glad I stayed patient and didn't buy in the 4s. It looks like a down week for the markets in anticipation of Fed statements at Jackson Hole. I might buy in at low 3s.
Here Are The Mid $3's
testing floor of support today....
One may not see 3's again
but never say never......lol.
IMO, floor of support may be as low as $3.60ish
Oh it will come but only after the US legalizes and all these other fly by night operations get put out of business. How long this takes is something is beyond me.
You must mean 50.00 and it’s coming in 2024.
Or just wait for .50...
Probably be a REALLY LONG time though
If you're really lucky we might see 1's
Omg I might just wait a bit more my 2s may show up
TLRY looking to be one of the Top of The List on Pot stocks, Charts look like 2 days close above of $4.15 confirm the next move up!
https://schrts.co/sMNPIJBN
2 days close above $4.50 even better
Staying above $4.00 is needed too:
http://www.stockta.com/cgi-bin/analysis.pl?symb=TLRY&cobrand=&mode=stock
12 after the great biden makes pot legal
im kicking myself for not buying a month ago
I'm on bidden everyday about setting the people of America free to enjoy. i said joe its like drinking a cup of tea. free the people
Wall Did You Get Your 3's Today? :)
50 day MA = ~$3.57; which is support?
Cannabis Amnesty Retweeted
Matt Lamers ????
@matt_lamers
Thousands still being added to this list every year. RCMP laid 6,259 cannabis-related charges since legalization in Canada since late 2018.
2019-20: 3,139 charges
2020-21: 3,120 charges
*****1000% They will !!! Europe , Germany , Canada all ahead of the USA - ( Far too much corruption in USA ) To get it done when it comes to legalizing MJ - Tilray does not need the US to benefit huge in the market - Simon has already stated many companies will not survive Tilray will continue to acquire companies
Europe could legalise before the US ... and that would benefit Tilray...
https://www.dw.com/en/germany-will-legalize-cannabis-but-nobody-knows-when/a-62810179
"Smoking weed should eventually become legal in Germany. The political will is there. But actually implementing it is hampered by international law, bureaucracy and tax rules. Activists want the process sped up."
TLRY PPS Direction Depends On US MJ Legislation?
7/21/22 https://www.politico.com/news/2022/07/21/schumer-legal-weed-bill-00047058
While marijuana legalization has spread rapidly across the U.S. over the past decade, Capitol Hill has not transitioned as quickly. Nineteen states now allow anyone at least 21 years old to possess and use the drug, and 37 states have established medical marijuana programs. National polls have consistently shown that roughly two-thirds of Americans back marijuana legalization, and support is even higher among younger voters.
But the votes aren’t yet there to pass Schumer’s bill on Capitol Hill.
That’s in part because many lawmakers from states with legal markets don’t yet support substantial changes to federal law. Democratic Sen. Jon Tester, for example, represents a state where weed is legal — Montana — and says he does not support federal decriminalization. A handful of other Democrats told POLITICO that they are against legalization or are undecided, including Sens. Jeanne Shaheen (D-N.H.), Joe Manchin (D-W.Va.) and Bob Casey (D-Pa.). Schumer would need all Democrats, plus ten Republicans, to get the bill over the finish line.
One may not see 3's again
but never say never......lol.
IMO, floor of support may be as low as $3.60ish
Grrrrrr I guess I will take 3s at this point
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*DISCLAIMER *The Board Monitor and herewith, are not licensed brokers and assume NO responsibility for the actions,
investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |